Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

teeing up an option decision that could establish Merck as a global rival to Daiichi Sankyo and Ono Pharmaceutical in the ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

While Merck's oncology powerhouse Keytruda delivered another multibillion-dollar sales haul in the third quarter, regional ...

Rahway, New Jersey Wednesday, November 13, 2024, 13:00 Hrs [IST] ...

With a market cap of $258 billion, Merck & Co., Inc. (MRK) is a global healthcare company, operating in the pharmaceutical and animal health sectors. Based in Rahway, New Jersey, Merck develops ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Notably, the study also showed that treatment with pimicotinib provided statistically significant and clinically meaningful improvements in secondary endpoints associated with important patient ...

global clinical development, Merck Research Laboratories, are scheduled to participate in a fireside chat at the UBS Global Healthcare Conference on Wednesday, Nov. 13, 2024, at 12:30 p.m. EST / 9 ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., and Dr. Joerg Koglin, senior vice president and head of ...